ID30339A - Metode pengobatan baru - Google Patents

Metode pengobatan baru

Info

Publication number: ID30339A
Authority: ID; Indonesia
Prior art keywords: treatment method; new treatment; new; treatment
Prior art date: 1999-04-15

Application number

IDW00200102237A

Other languages

English (en)

Indonesian (id)

Inventor

Colin Houston Dr Macphee

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-15

Filing date

2000-04-17

Publication date

2001-11-22

2000-04-17 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2001-11-22 Publication of ID30339A publication Critical patent/ID30339A/id

Links

Classifications

- G—PHYSICS
- G11—INFORMATION STORAGE
- G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
- G11B20/00—Signal processing not specific to the method of recording or reproducing; Circuits therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Immunology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Rheumatology (AREA)
Oncology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Transplantation (AREA)
Obesity (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
AIDS & HIV (AREA)

IDW00200102237A 1999-04-15 2000-04-17 Metode pengobatan baru ID30339A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9908647.2A GB9908647D0 (en)	1999-04-15	1999-04-15	Novel compounds

Publications (1)

Publication Number	Publication Date
ID30339A true ID30339A (id)	2001-11-22

Family

ID=10851605

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW00200102237A ID30339A (id)	1999-04-15	2000-04-17	Metode pengobatan baru

Country Status (32)

Country	Link
EP (2)	EP1593379A3 (fr)
JP (1)	JP2003516310A (fr)
KR (1)	KR20010108506A (fr)
CN (1)	CN1413105A (fr)
AP (1)	AP2001002291A0 (fr)
AT (1)	ATE319437T1 (fr)
AU (1)	AU4583000A (fr)
BG (1)	BG106104A (fr)
BR (1)	BR0009776A (fr)
CA (1)	CA2370127A1 (fr)
CZ (1)	CZ20013688A3 (fr)
DE (1)	DE60026508T2 (fr)
DK (1)	DK1274407T3 (fr)
DZ (1)	DZ3151A1 (fr)
EA (1)	EA200101089A1 (fr)
ES (1)	ES2256003T3 (fr)
GB (1)	GB9908647D0 (fr)
HK (1)	HK1053788A1 (fr)
HR (1)	HRP20010746A2 (fr)
HU (1)	HUP0300479A2 (fr)
ID (1)	ID30339A (fr)
IL (1)	IL145875A0 (fr)
MA (1)	MA25351A1 (fr)
MX (1)	MXPA01010428A (fr)
NO (1)	NO20014950L (fr)
PL (1)	PL364720A1 (fr)
PT (1)	PT1274407E (fr)
SK (1)	SK14532001A3 (fr)
TR (1)	TR200102977T2 (fr)
WO (1)	WO2000062766A2 (fr)
YU (1)	YU77901A (fr)
ZA (1)	ZA200108446B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9913782D0 (en) *	1999-06-14	1999-08-11	Smithkline Beecham Plc	Novel compounds
AU2001223488A1 (en) *	2000-11-09	2002-05-21	Phenion Gmbh And Co. Kg	Activators of peroxisome proliferator-activated alpha and beta receptors as medicaments for treating skin disorders having immunological causes
GB0030845D0 (en) *	2000-12-18	2001-01-31	Smithkline Beecham Plc	Novel treatment
GB2373725A (en) *	2001-03-30	2002-10-02	Novartis Ag	Use of a PPAR gamma agonist in the production of a medicament for the prevention or treatment of diseases associated with IL-10 production
JP2005513031A (ja) *	2001-11-26	2005-05-12	アラクノーバ・セラピューティックス・リミテッド	肺線維症の処置のためのｐｐａｒアクチベーターの使用
DE10204398A1 (de) *	2002-02-04	2003-08-14	Univ Goettingen Georg August	Neue Verwendung von Liganden der 'Peroxisome Proliferator-Activated receptors'(PPAR)
US6992093B2 (en)	2002-05-02	2006-01-31	Los Angeles Biomedical Research Institute At Harbor Ucla Medical Center	Method of inhibiting lipofibroblast to myofibroblast transdifferentiation
US8293479B2 (en)	2002-05-02	2012-10-23	Los Angeles Biomedical Research Institute At Harbor Ucla Medical Center	Use of parathyroid hormone-related protein(PTHRP) in the diagnosis and treatment of chronic lung disease and other pathologies
US20030220300A1 (en) *	2002-05-14	2003-11-27	Hwang Cheng Shine	Reduction of hair growth
ITRM20050389A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
KR101333089B1 (ko)	2006-05-22	2013-11-27	재단법인 아산사회복지재단	로지글리타존을 유효성분으로 함유하는 흡연-유발 만성폐쇄성 폐질환 예방 또는 치료용 약제학적 조성물
GB0913672D0 (en)	2009-08-05	2009-09-16	Argenta Discovery Ltd	Glitazones
US8236786B2 (en)	2008-08-07	2012-08-07	Pulmagen Therapeutics (Inflammation) Limited	Respiratory disease treatment
NZ590774A (en) *	2008-08-07	2012-09-28	Pulmagen Therapeutics Inflammation Ltd	Substantially pure 5R enantiomers of pioglitazone and rosiglitazone for treating inflammatory respiratory diseases
UA107562C2 (uk)	2008-12-05	2015-01-26		Спосіб лікування псоріазу
MX2011007036A (es)	2008-12-30	2011-07-20	Pulmagen Therapeutics Inflammation Ltd	Compuestos de sulfonamida para el tratamiento de trastornos respiratorios.
WO2010091894A2 (fr)	2009-02-16	2010-08-19	Giuliani International Limited	Méthodes de traitement de troubles liés aux cheveux
WO2010150014A1 (fr)	2009-06-24	2010-12-29	Pulmagen Therapeutics (Inflammation) Limited	Glitazones 5r-5–deutérés pour le traitement de maladies respiratoires
WO2011098746A1 (fr)	2010-02-09	2011-08-18	Pulmagen Therapeutics (Inflammation) Limited	Sels d'addition acide cristallins de l'énantiomère (5r) de la pioglitazone
GB201002243D0 (en)	2010-02-10	2010-03-31	Argenta Therapeutics Ltd	Respiratory disease treatment
GB201002224D0 (en)	2010-02-10	2010-03-31	Argenta Therapeutics Ltd	Respiratory disease treatment
CN109999017A (zh)	2012-02-09	2019-07-12	诺格拉制药有限公司	治疗纤维化的方法
CN104284655B (zh)	2012-04-18	2017-10-27	诺格拉制药有限公司	治疗乳糖不耐受的方法
AU2015315324A1 (en) *	2014-09-08	2017-03-09	Dana-Farber Cancer Institute, Inc.	Methods of treating cancer comprising administering a PPAR-gamma agonist
CA3049856C (fr) *	2017-01-13	2021-10-26	Tobishi Pharmaceutical Co., Ltd.	Regulateur d'activation des neutrophiles
EP4495101A3 (fr)	2019-02-08	2025-04-30	Nogra Pharma Limited	Procédé de fabrication d'acide 3-(4'-aminophényl)-2-méthoxypropionique, et analogues et intermédiaires de celui-ci
JP2020145939A (ja) *	2019-03-12	2020-09-17	日本製粉株式会社	アレルギー性鼻炎抑制用組成物
CN116531374A (zh) *	2023-04-20	2023-08-04	中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所)	吡格列酮及其盐在制备用于治疗系统性红斑狼疮的产品中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9611947D0 (en) *	1996-06-07	1996-08-07	Glaxo Group Ltd	Medicaments
JPH10139665A (ja) *	1996-09-12	1998-05-26	Sankyo Co Ltd	トログリタゾンを含有するグルタチオン還元酵素活性増強剤
ATE462433T1 (de) *	1996-12-11	2010-04-15	Dana Farber Cancer Inst Inc	Methoden und pharmazeutische zusammensetzungen zur inhibition des tumorwachstums
CA2276288A1 (fr) *	1996-12-31	1998-07-09	Laszlo Nagy	Traitement des etats pathologiques generes par la proliferation cellulaire neoplasique au moyen d'activateurs ppar-gamma et compositions utiles a cet effet
FR2773075B1 (fr) *	1997-12-31	2000-05-05	Cird Galderma	Utilisation d'activateurs de ppar-gamma en dermatologie
US6028088A (en) *	1998-10-30	2000-02-22	The University Of Mississippi	Flavonoid derivatives

1999
- 1999-04-15 GB GBGB9908647.2A patent/GB9908647D0/en not_active Ceased
2000
- 2000-04-11 DZ DZ003151A patent/DZ3151A1/fr active
- 2000-04-17 EA EA200101089A patent/EA200101089A1/ru unknown
- 2000-04-17 AU AU45830/00A patent/AU4583000A/en not_active Abandoned
- 2000-04-17 MX MXPA01010428A patent/MXPA01010428A/es unknown
- 2000-04-17 PT PT00927425T patent/PT1274407E/pt unknown
- 2000-04-17 HK HK03104497.7A patent/HK1053788A1/zh unknown
- 2000-04-17 EP EP05076787A patent/EP1593379A3/fr not_active Withdrawn
- 2000-04-17 EP EP00927425A patent/EP1274407B1/fr not_active Expired - Lifetime
- 2000-04-17 ID IDW00200102237A patent/ID30339A/id unknown
- 2000-04-17 HR HR20010746A patent/HRP20010746A2/hr not_active Application Discontinuation
- 2000-04-17 DK DK00927425T patent/DK1274407T3/da active
- 2000-04-17 BR BR0009776-4A patent/BR0009776A/pt not_active IP Right Cessation
- 2000-04-17 SK SK1453-2001A patent/SK14532001A3/sk unknown
- 2000-04-17 ES ES00927425T patent/ES2256003T3/es not_active Expired - Lifetime
- 2000-04-17 JP JP2000611903A patent/JP2003516310A/ja active Pending
- 2000-04-17 AT AT00927425T patent/ATE319437T1/de not_active IP Right Cessation
- 2000-04-17 YU YU77901A patent/YU77901A/sh unknown
- 2000-04-17 AP APAP/P/2001/002291A patent/AP2001002291A0/en unknown
- 2000-04-17 CA CA002370127A patent/CA2370127A1/fr not_active Abandoned
- 2000-04-17 DE DE60026508T patent/DE60026508T2/de not_active Expired - Lifetime
- 2000-04-17 KR KR1020017013106A patent/KR20010108506A/ko not_active Ceased
- 2000-04-17 HU HU0300479A patent/HUP0300479A2/hu unknown
- 2000-04-17 IL IL14587500A patent/IL145875A0/xx unknown
- 2000-04-17 PL PL00364720A patent/PL364720A1/xx not_active Application Discontinuation
- 2000-04-17 WO PCT/GB2000/001499 patent/WO2000062766A2/fr not_active Ceased
- 2000-04-17 TR TR2001/02977T patent/TR200102977T2/xx unknown
- 2000-04-17 CZ CZ20013688A patent/CZ20013688A3/cs unknown
- 2000-04-17 CN CN00809014A patent/CN1413105A/zh active Pending
2001
- 2001-10-11 NO NO20014950A patent/NO20014950L/no not_active Application Discontinuation
- 2001-10-12 MA MA26355A patent/MA25351A1/fr unknown
- 2001-10-15 ZA ZA200108446A patent/ZA200108446B/xx unknown
- 2001-11-13 BG BG106104A patent/BG106104A/xx unknown

Also Published As

Publication number	Publication date
EP1593379A3 (fr)	2007-10-31
ATE319437T1 (de)	2006-03-15
GB9908647D0 (en)	1999-06-09
EA200101089A1 (ru)	2002-10-31
NO20014950D0 (no)	2001-10-11
JP2003516310A (ja)	2003-05-13
PL364720A1 (en)	2004-12-13
YU77901A (sh)	2005-07-19
NO20014950L (no)	2001-12-13
HUP0300479A2 (hu)	2003-07-28
DK1274407T3 (da)	2006-06-26
WO2000062766A3 (fr)	2002-10-31
WO2000062766A2 (fr)	2000-10-26
EP1274407B1 (fr)	2006-03-08
DE60026508T2 (de)	2006-11-16
ZA200108446B (en)	2003-08-27
SK14532001A3 (sk)	2002-02-05
AP2001002291A0 (en)	2001-12-31
BR0009776A (pt)	2002-06-04
EP1274407A2 (fr)	2003-01-15
TR200102977T2 (tr)	2002-09-23
MA25351A1 (fr)	2001-12-31
PT1274407E (pt)	2006-06-30
DZ3151A1 (fr)	2000-10-19
CN1413105A (zh)	2003-04-23
ES2256003T3 (es)	2006-07-16
DE60026508D1 (de)	2006-05-04
HRP20010746A2 (en)	2002-10-31
HK1053788A1 (zh)	2003-11-07
IL145875A0 (en)	2002-07-25
CA2370127A1 (fr)	2000-10-26
MXPA01010428A (es)	2002-05-06
EP1593379A2 (fr)	2005-11-09
KR20010108506A (ko)	2001-12-07
CZ20013688A3 (cs)	2003-03-12
BG106104A (en)	2002-05-31
AU4583000A (en)	2000-11-02

Publication	Publication Date	Title
ID30339A (id)	2001-11-22	Metode pengobatan baru
FI20000863L (fi)	2000-10-13	Uusi hoitomenetelmä
DE60028849D1 (de)	2006-08-03	Sterilisationsmethode
DE69828821D1 (de)	2005-03-03	Wasserbehandlungsverfahren
DE60040607D1 (de)	2008-12-04	Wasserbehandlungseinrichtung
DE60041641D1 (de)	2009-04-09	Plasma behandlungsapparat
DE60017514D1 (de)	2005-02-24	Laserbehandlungsgerät
ID30025A (id)	2001-11-01	Metode perlakuan tekstil
DE60030210D1 (de)	2006-10-05	Elektrolytisches Behandlungsverfahren
DE60023454D1 (de)	2005-12-01	Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
NO20005179D0 (no)	2000-10-13	Medikament behandling
NO20013337L (no)	2001-08-17	Ny behandling
ID19542A (id)	1998-07-23	Pengobatan baru
NO20013596L (no)	2001-08-20	Slambehandling
DE60037935D1 (de)	2008-03-20	Kontinuierliches behandlungssystem
ATE302165T1 (de)	2005-09-15	Wasserbehandlung
ID25984A (id)	2000-11-16	Metode pengeringan cat-dasar
DE19883020T1 (de)	2002-04-25	Entladungsoberflächen-Behandlungsverfahren
DE69912763D1 (de)	2003-12-18	Behandlungsanlage
DK1135128T3 (da)	2007-11-05	Nye behandlingsfremgangsmåder
ID29042A (id)	2001-07-26	Metode pengobatan baru
ATA203199A (de)	2001-03-15	Ablauf
SE9903421D0 (sv)	1999-09-22	Behandlingsförfarande
ID26641A (id)	2001-01-25	Metoda pengobatan
SE9802791D0 (sv)	1998-08-19	Behandlingsmetod